Leading global brokerages have updated their views on key Indian stocks as of July 1, adjusting their ratings and target prices in response to recent developments and business performance. Here’s a summary of the latest brokerage actions:
-
Polycab: Jefferies has maintained its ‘Buy’ rating with a target price of ₹7,150 per share.
-
Apollo Hospitals: Citi has reiterated its ‘Buy’ call with a target of ₹8,260, while Morgan Stanley has maintained an ‘Overweight’ rating with a target price of ₹8,058.
-
DLF: CLSA continues to rate the stock as ‘Outperform’ with a price target of ₹1,025.
-
Reliance Industries: Nuvama has reaffirmed its ‘Buy’ rating with a target price of ₹1,801.
-
Torrent Pharmaceuticals: Bank of America has maintained a ‘Neutral’ view and raised the target price to ₹3,500.
-
Ambuja Cements: Jefferies has kept a ‘Buy’ rating intact with a price target of ₹700.
-
OnsSource: DAM has initiated coverage with a ‘Buy’ call and a price target of ₹2,529.
-
Asian Paints: ICICI Securities has upgraded its rating to ‘Add’ and revised the target price to ₹2,700.
-
Berger Paints: ICICI Securities has also upgraded the stock to ‘Add’ with a higher target of ₹650.
-
ACC: CLSA has commented on the company’s focus on achieving its capacity expansion goal of 140 million tonnes by FY28.
-
Dixon Technologies: Morgan Stanley has downgraded the stock to ‘Underweight’ with a revised target price of ₹11,563.
Disclaimer: The views and recommendations expressed above are those of the respective brokerage firms. They do not represent the views of this publication and are not investment advice. Investors are advised to consult with certified financial advisors before making any investment decisions.
